COMMUNIQUÉS West-GlobeNewswire

XORTX Patent Allowed for XRx-101 Program by Japan Patent Office
13/11/2026
Japan Patent Office allows claims directed to xanthine oxidase inhibitor compositions for acute kidney injury and other health consequences of viral infection; once registered, patent expected to remain in force until [...]
Oncolytics Biotech® Announces Clinical Supply Agreement to Evaluate Pelareorep in Combination with LOQTORZI® (toripalimab-tpzi) in SCAC
13/11/2026
Pelareorep and toripalimab combine potentially complementary mechanisms designed to enhance antitumor immune responses and help overcome tumor immune resistance Study may represent a first step toward evaluating the [...]
Pennant Group to Participate in the 2026 Stephens Annual Investment Conference
13/11/2026
EAGLE, Idaho, Nov. 13, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]
Kura Oncology to Participate in Two Investor Conferences in November
13/11/2026
SAN DIEGO, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, today announced that management will present at [...]
Eclipse Energy and Weatherford Demonstrate Subsurface Hydrogen Migration Between Wells in the Permian
13/11/2026
Hydrogen generated underground was recovered in multiple wells and moved through existing commercial infrastructure HOUSTON, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Eclipse Energy, a Houston-based energy technology company [...]
Novartis receives positive CHMP opinion for Cosentyx® in adolescents aged 12+ with hidradenitis suppurativa (HS)
13/11/2026
If approved, Cosentyx ® (secukinumab) will become the only IL-17A inhibitor for adolescents with moderate to severe HS in Europe 1,2 HS affects as many as one in 100 people worldwide, 3 with more than half developing [...]
CORRECTION -- Park Dental Partners Announces Third Quarter 2026 Results
13/11/2026
This press release corrects the “Percent Change (At Midpoint)” in the outlook table contained in the Company's press release originally issued on November 12, 2026. The corrected table is included herein. There were no [...]
Silexion Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
13/11/2026
First patient dosed in the Phase 2/3 clinical trial of SIL204 in locally advanced pancreatic cancer at Tel Aviv Sourasky Medical Center, moving SIL204 into active patient treatment New translational data expanded SIL204 [...]
UPDATED -- Benitec Biopharma Releases First Quarter 2027 Fiscal-Year Financial Results and Provides Operational Update
13/11/2026
Positive interim clinical results from the ongoing BB-301 Phase 1b/2a study for dysphagic patients with Oculopharyngeal Muscular Dystrophy (OPMD), presented as a late-breaking poster at the European Society of Gene and [...]
Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update
13/11/2026
AlterG revenue increased 18% year-over-year to $3.6 million, driven by higher U.S. unit shipments, service revenue and average selling prices The Company is advancing its transition of ReWalk to a capital-efficient [...]
Sol y Vida Recognizes National Diabetes Awareness Month, Honoring the Families and Communities Leading the Way on Early Detection
13/11/2026
Bilingual clinic joins the Latino Diabetes Association in encouraging Latino families to learn their risk and talk with a doctor LOS ANGELES, Nov. 13, 2026 (GLOBE NEWSWIRE) -- In recognition of National Diabetes [...]
COSCIENS Biopharma Inc. Reports Q3 2026 Results and Provides Update On Convertible Debenture Offering
13/11/2026
TORONTO, ONTARIO, Nov. 13, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“ COSCIENS ” or the “ Company ”) today reported its financial and operating results for the third quarter ended [...]
Zealand Pharma announces EU approval of Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
13/11/2026
Press release – No. 24 / 2026 Zealand Pharma announces EU approval of Zeydovio TM (glepaglutide) for the treatment of short bowel syndrome The approval marks the first major advancement in short bowel syndrome treatment [...]
CUKTECH Makes MPL Malaysia S18 Playoffs Debut to Champion Reliable Power and Peak Performance in Esports
13/11/2026
KUALA LUMPUR, Nov. 13, 2026 (GLOBE NEWSWIRE) -- CUKTECH made its debut at the Mobile Legends: Bang Bang (MLBB) Professional League (MPL) Malaysia Season 18 Playoffs as the league's Strategic Partner for the Powerbank [...]
RAMSAY GENERALE DE SANTE : ASSEMBLEE GENERALE MIXTE DU 4 DECEMBRE 2026
13/11/2026
INFORMATION REGLEMENTAIRE Paris, le 13 novembre 2026 ASSEMBLEE GENERALE MIXTE DU 4 DECEMBRE 2026 Convocation de l’Assemblée Générale Mixte de Ramsay Générale de Santé Modalités de mise à disposition ou de consultation [...]
RAMSAY GENERALE DE SANTE : COMBINED GENERAL MEETING OF DECEMBER 4, 2026
13/11/2026
REGULATORY INFORMATION Paris, 13 November 2026 COMBINED GENERAL MEETING OF DECEMBER 4, 2026 Convening of the Ramsay Générale de Santé General Meeting Conditions of availability and consultation of the preparatory [...]
FREHEMGO® (denecimig) approved in the EU for haemophilia A, with a choice of monthly, every-two-weeks or weekly dosing
13/11/2026
European Commission (EC) grants marketing authorisation for FREHEMGO® (denecimig) for haemophilia A (congenital FVIII deficiency), with or without inhibitors, in adults and children. FREHEMGO® is the first FVIIIa [...]
HealthEx Joins Sierra’s Personal Agent Protocol as a Design Partner
13/11/2026
HealthEx will help shape how personal AI agents work with healthcare organizations, bringing experience in verified identity, consent, and personal health context SAN FRANCISCO, Nov. 13, 2026 (GLOBE NEWSWIRE) -- [...]
Rezolute Announces Positive Results from the Phase 3 upLIFT Study in Tumor Hyperinsulinism
13/11/2026
Primary efficacy endpoint achieved based on preliminary results from a November 5 th data evaluation Topline results for the completed study, along with additional study details including statistical analysis of the [...]

Pages